Detalhe da pesquisa
1.
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin.
Liver Int
; 34(10): 1550-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24329937
2.
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
PLoS One
; 11(3): e0151703, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27018988